Journal of International Oncology››2014,Vol. 41››Issue (11): 862-865.doi:10.3760/cma.j.issn.1673-422X.2014.11.019
Previous ArticlesNext Articles
Online:
2014-12-03Published:
2015-01-20Contact:
Xing Zhenyu, Email: cherokeeman@sohu.comXING Zhen-Yu, ZHANG Hui-Di, GAO Lei, CHANG Wen-Long, TIAN Shao-Hui, ZHANG Hui. Effect of disodium cantharidinate on in vitro lymphocyte immune response in lung cancer patients[J]. Journal of International Oncology, 2014, 41(11): 862-865.
[1] Liu D, Chen Z. The effects of cantharidin and cantharidin derivates on tumour cells[J]. Anticancer Agents Med Chem, 2009, 9(4):392396. [2] 刘健, 高建辉, 刘晓秋. 斑蝥素及其衍生物的研究进展[J] . 中药材, 2003, 26(6):453455. [3] 房德芳, 王明艳. 几种有毒动物药材及其有效成分抗癌作用的研究进展[J]. 江苏中医药, 2007, 39(11):9293. [4] 施秀青, 徐瑞荣. 斑蝥素及其衍生物抗肿瘤作用机制的研究进展[J]. 浙江中西医结合杂志, 2007, 17(12):792793. [5] 鲁祥石, 李令根, 王志华. 斑蝥酸钠维生素B6在乳腺癌辅助化疗中的应用[J]. 中国基层医药, 2012, 19(9):12911292. [6] 汪晓凤, 罗新华. 斑蝥酸钠维生素B6注射液辅助治疗肝癌随机对照的Meta分析[J]. 国际肿瘤学杂志, 2014, 41(1):6973. [7] 蒋淑年, 扬帆, 马兆明. 斑蝥酸钠配合三维适形放疗治疗食管癌近期疗效观察[J].齐齐哈尔医学院学报, 2010, 31(20):32583259. [8] 巴德年. 当代免疫学技术与应用[M]. 北京: 北京医科大学中国协和医科大学联合出版社, 1998:352356. [9] 王迎利, 王丽萍. 斑蝥酸钠维生素B6 注射液对改善非小细胞肺癌多药耐药研究[J]. 中国中医基础医学杂志, 2013, 19(9):10881089. [10] 陆东东. 大肠癌肺癌患者白细胞对抗癌药物敏感性的测定分析[J]. 中国慢性病预防与控制, 1998, 6(6):287289. [11] 曲韬, 唐裕福. 微波消融治疗对肝癌小鼠调节性T细胞的影响[J]. 现代肿瘤医学, 2014, 22(3):523526. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | He Jiahui, Hu Qinyong.Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data[J]. Journal of International Oncology, 2024, 51(1): 29-36. |
[3] | Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng.Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection[J]. Journal of International Oncology, 2023, 50(12): 711-716. |
[4] | Chen Yu, Xu Hua, Liu Hai, Chen Shixin.Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging[J]. Journal of International Oncology, 2023, 50(11): 655-660. |
[5] | Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun.Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model[J]. Journal of International Oncology, 2022, 49(9): 532-536. |
[6] | Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying.Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses[J]. Journal of International Oncology, 2022, 49(8): 459-463. |
[7] | Cai Gangxiang, Li Jing, Xu Bin.Advances in neoadjuvant immunotherapy for lung cancer[J]. Journal of International Oncology, 2022, 49(6): 366-370. |
[8] | Zhang Jingxian, Yi Dan, Li Xiaojiang.Application of antibody-drug conjugates in the treatment of non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(5): 296-301. |
[9] | Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei.Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer[J]. Journal of International Oncology, 2022, 49(4): 247-251. |
[10] | Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu.Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(3): 140-145. |
[11] | Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming.Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(2): 111-115. |
[12] | Huang Huayu, Song Qibin, Gong Hongyun, Song Jia.Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy[J]. Journal of International Oncology, 2022, 49(12): 718-723. |
[13] | Zhang Hongjiao, Jiang Jie, Huang Wei.Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis[J]. Journal of International Oncology, 2022, 49(1): 51-55. |
[14] | Hu Ge, Su Jie, Li Qiangwei, Xu Peng, Xu Xiuli, Qian Xiaotao.Value of CD4/CD8 ratio and total B lymphocytes before radiotherapy in predicting radiation pneumonitis in patients with esophageal cancer and lung cancer[J]. Journal of International Oncology, 2021, 48(9): 523-526. |
[15] | Wang Jun, Zhao Xia, Li Haifei, Zhang Cheng.Clinic diagnostic value of MSCT imaging features in nodular lung adenocarcinoma subtype[J]. Journal of International Oncology, 2021, 48(9): 537-543. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||